Advanced Medical Solutions Grp PLC Capital Markets Day (0169R)
24 June 2015 - 4:00PM
UK Regulatory
TIDMAMS
RNS Number : 0169R
Advanced Medical Solutions Grp PLC
24 June 2015
24 June 2015
Advanced Medical Solutions Group plc
("AMS" or the "Group")
Capital Markets Day
Winsford, UK, 24 June 2015 - Advanced Medical Solutions Group
plc (AIM: AMS.L), the surgical and advanced woundcare specialist
company, will today host a Capital Markets Day for financial
analysts and institutional investors from 12:30 - 16:00 GMT, in
London.
The event, which will provide an opportunity for participants to
meet some of the Group's senior management team, will begin with a
short corporate update on strategy from Chris Meredith, Chief
Executive Officer, followed by a focus on LiquiBand(R) in the US
market, a surgeon discussion led by Assistant Professor Bernhard
Dauser from the Department of Surgery at St John of God Hospital,
Vienna, on the benefits of LiquiBand(R) Fix 8(R) , and a session on
innovation and market opportunities across the complete AMS product
platform.
No new material information will be disclosed during the
event.
For more information, please contact ams@consilium-comms.com or
call +44 (0) 20 3709 5700.
- Ends -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group plc
Chris Meredith, Chief Executive Officer
Mary Tavener, Group Finance Director +44 (0) 1606 545508
Consilium Strategic Communications +44 (0) 20 3709 5700
Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Ivar Milligan AMS@consilium-comms.com
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical, wound care and wound closure markets, focused on quality
outcomes for patients and value for payors. AMS has a wide range of
products that include silver alginates, alginates, foams, tissue
adhesives, sutures and haemostats, which it markets under its
brands ActivHeal(R) , LiquiBand(R) and RESORBA(R) as well as
supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in 65 countries via a network of multinational or regional
partners and distributors, as well as via AMS's own direct sales
forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Group has approximately 470 employees. For
more information please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEAKKDADSSEFF
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2024 to May 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From May 2023 to May 2024